Abstract
Down syndrome is the most common cause of mental retardation, affecting 1 in 700–800 liveborn infants. Although numerous biochemical abnormalities accompanying the syndrome have not yet been completely clarified, the antioxidant defense system enzymes have shown to be altered due to increased gene dosage on chromosome 21 and overproduction of superoxide dismutase (SOD-1 or Cu/Zn SOD). The purpose of this study was to investigate the activities of SOD-1 and glutathione peroxidase (GSH-Px) enzymes and the levels of their cofactors zinc (Zn), copper (Cu) and selenium (Se) in plasma of 20 Down syndrome patients.
In comparison with age and sex-matched controls (n=15), plasma GSH-Px, SOD, and Cu levels were significantly decreased in the patient group, but Zn and Se concentrations remained unchanged.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. Cebellos-Picot, A. Nicole, P. Briand, G. Grimber, A. Delacourte, A. Defossez, F. Javoy-Agid, M. Lafon, J. L. Blouin, and P. M. Sinet,Brain Res. 552, 198–214 (1991).
J. Kedziora, J. Blaszczyk, E. Sibinska, and G. Bartosz,Hereditas 113, 73–75 (1990).
K. G. Anneren and C. J. Epstein, Ped. Res.21, 88–92 (1987).
J. Neve, F. Vertognen, P. Cauchie, D. Gnat, and L. Molle,J. Ment. Defic. Res. 28, 261–268 (1984).
G. Anneren, M. Gebre-Medhin, and K. H. Gustavson,Acta Paediatr Scand. 78, 879–884 (1989).
N. Crosti, J. Bajer, M. Gentile, G. Resta, and A. Serra,Clin. Genet. 36, 107–116 (1989).
I. Ceballos-Picot, A. Nicole, and P. M. Sinet,Exs. 62, 89–98 (1992).
K. L. Brugge, S. Nichols, D. Delis, T. Saitoh, and D. Truaner,Exs. 62, 190–198 (1992).
D. Minc-Golomb, H. Knobler, and Y. Groner,Embo J. 10, 2119–2124 (1991).
B. W. L. Brooksbank and R. Balazs,Dev. Brain Res. 16, 37–44 (1984).
M. J. Dickinson and I. Singh,British J of Psychiatry. 162, 811–817 (1993).
T. Portsmann, R. Wietschke, G. Cobet, G. Stamminger, R. Bolmans, V. Rogalskis, and P. Pas,Prenat. Diag. 11, 295–303 (1991).
G. Bartosz, J. Kedziora, and W. Retelewska,Clin. Chim. Acta. 198, 239–244 (1991).
N. Kurabe, F. Suzuki, K. Okajima, and K. Kato,Clin. Chim. Acta. 187, 11–20 (1990).
J. B. de-Haan, F. Cristiano, R. Iannellr, C. Bladier, M. J. Kelner, and I. Kola,Hum. Mol. Genet. 2, 283–292 (1996).
J. Kadrabova, A. Madaric, M. Sustrova, and E. Ginter,Biol. Trace Elem. Res. 54, 201–206 (1996).
A. Yenigün, F. özkinay, O. Coĝulu, C. Coker, N. Çetiner, G. Özden, C. Ozkinay, and O. Aksu, The European Society of Hum. Genet, Genoa, Italy, Abstract Book, 24, (1997).
R. S. Bedwal, N. Nair, M. P. Sharma, and R. S. Mathur,Med. Hypotheses. 41, 150–159, (1993).
M. Chiricola, A. R. Musa, D. Monti, M. Zannotti, and C. Franceschi,Mut. Res. 295, 105–111 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tekşen, F., Şayli, B.S., Aydin, A. et al. Antioxidative metabolism in down syndrome. Biol Trace Elem Res 63, 123–127 (1998). https://doi.org/10.1007/BF02778871
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02778871